NIFTY
-91.80  -0.92% 		 9872.60
S&P BSE SENSEX
-295.81  -0.93% 		 31626.63
Divis Laboratories Ltd.
NSE : DIVISLAB BSE : 532488 ISIN code : INE361B01024
on 25-Sep-2017
NSE
-17.55    -1.81%
Rs. 952.70
 
Days Low
Rs. 932.1 		Days High
Rs. 977

Open Rs. 972
 
52 week Low
Rs. 533.1 		52 week High
Rs.1349.95
 
 
Bid :                 955.00 (205)
Offer :        0.00 (0)
BSE
Rs.952.10
-16.9    -1.74%
on 25-Sep-2017
BSE
-16.9    -1.74%
Rs. 952.10
 
Days Low
Rs. 930.45 		Days High
Rs. 972

Open Rs. 969.8
 
52 week Low
Rs. 532.65 		52 week High
Rs.1351.35
 
 
Bid :                 955.00 (205)
Offer :        0.00 (0)
NSE
Rs.952.70
-17.55    -1.81%
Summary Company Information Fund Holdings
Chart Display Advance Chart
Profit & Loss Balance Sheet Cash Flow Financial Ratios Quarterly Results
 
 
Last Price (Rs.)  952.10 Value  610086112.00
Net Change (Rs.)  -16.90 Best Buy  955.00
Volume  643346 Best Sell  0.00
Prev.Close (Rs.)  969.00 Best Quantity  205
Open (Rs.)  972.00 Sell Quantity  0
High (Rs.)  977.00 52-Week High (Rs.)  1349.95
Low (Rs.)  932.10 52-Week Low (Rs.)  533.10
Face Value (Rs.)  2 Market Cap.(Rs/ Mn)  252752.64
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital530.94 530.94 265.47 
Share Capital530.94 530.94 265.47 
Share Capital530.94 530.94 265.47 
Share Capital530.94 530.94 265.47 
Share Capital530.94 530.94 265.47 
Currents Investments16307.22 8028.52 7330.04 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 505.90 1213809 81.60 0.00 0.69
Cadila Healthcare 481.55 492983 65.54 74.50 0.66
Piramal Enterprises 2704.85 466757 838.20 60.08 0.78
Cipla 576.90 464223 161.56 47.60 0.35
Lupin 991.30 447867 331.14 14.25 0.76
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2017Mar 2017Dec 2016
Net Sales8212.0010666.709630.50
Operating Profit2745.003829.303992.70
PBDT2740.103818.903988.30
Net Profit1765.402592.902683.20
More> 
 
Company News
9/25/2017 12:00:00 AM
Outcome of AGM
9/20/2017 12:00:00 AM
Divis Laboratories trades jubilantly on the bourses
9/20/2017 12:00:00 AM
Divi’s Laboratories gets form 483 citing six procedural observations f...
More>
 
Ratios
   Earnings Per Share (Rs)39.68 
   Book NAV/Share(Rs)203.75 
   PAT Margin (%)25.91 
   Asset Turnover(x)0.73 
   PER(x)15.73 
   Yield(%)1.60 
   EV/Core EBITDA(x)10.92 
   M Cap / Sales4.12 
   Net Sales Growth(%)8.13 
   PAT Growth(%)-5.18 
   Total Debt/Equity(x)0.01 
   Current Ratio(x)6.16 
   Quick Ratio(x)4.24 
   Total Debt/Mcap(x)0.00 
More>
 
Privacy Statement  |  Disclaimer  |  Terms of Use   |  Careers  |  Feedback  |   Terms and Conditions  |  Anti Money Laundering Measures  |  Important Policies   |  Dos & Donts   |   BSE  |   NSE  |   SEBI NCDEX  |   NSDL  |   CDSL  |   RBI  |   AMFI  |   Ministry of Finance  |   Government of India
Copyright © 2012, Khandwala Securities Limited MAPIN UIN100012369, NSE INF2306000030, BSE INB010600030, NCDEX: NCDEX-CO-05-00506, AMFI ARN: 1673, Certificate of Registration as Portfolio Manager INP000000340, Certificate of Registration as Merchant Banking – INM000001899, SEBI Registration No. INB 230600030 (NSE) INB 010600030 (BSE)
For Investor Grievance please mail to: :investorgrievances@kslindia.com
CIN NO. : L67120MH1993PLC070709
Designed, Developed & Content Powered by  ● ● ● Accord Fintech Pvt. Ltd    Best viewed in internet Explorer 7.0 or above